RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Poisoning
Accession: DOID:9000046
browse the term
Definition: A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.
Synonyms: exact_synonym: Poisonings
related_synonym: Benzene toxicity, susceptibility to
primary_id: MESH:D011041
xref: EFO:0008546
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23562926
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Ache
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17098105 PMID:19453088
RGD:5688054
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10511253
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20176007 PMID:20513442 PMID:21620937 PMID:21683774 PMID:29183815
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20044985
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cdkn2b
cyclin dependent kinase inhibitor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20044985
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
G
Csf3
colony stimulating factor 3 (granulocyte)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15727166
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cst3
cystatin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22525860
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20036648
NCBI chr 8:72,742,326...72,763,512
Ensembl chr 8:72,742,326...72,763,470
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15727166
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Gcg
glucagon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7629900
NCBI chr 2:62,304,874...62,313,997
Ensembl chr 2:62,304,874...62,313,994
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22975441
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Hand1
heart and neural crest derivatives expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21964422
NCBI chr11:57,719,539...57,722,973
Ensembl chr11:57,719,531...57,723,644
G
Il1a
interleukin 1 alpha
treatment
IDA ISO
RGD
PMID:1868253 PMID:2258610
RGD:11051971 , RGD:11059514
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ISO
ClinVar Annotator: match by term: Benzene toxicity, susceptibility to
ClinVar
PMID:1737339 PMID:6933553 PMID:9000600 PMID:9230185 PMID:9328142 PMID:9593466 PMID:9855009 PMID:10393869 PMID:10393963 PMID:18511948 More...
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Prkdc
protein kinase, DNA activated, catalytic polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20036648
NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22525860
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Xirp1
xin actin-binding repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21964422
NCBI chr 9:119,842,821...119,852,660
Ensembl chr 9:119,842,821...119,852,664
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:10235270
RGD:406351024
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cnr1
cannabinoid receptor 1
ISO
RGD
PMID:11841893
RGD:1626329
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum
RGD
PMID:17434673
RGD:401965399
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:16318954
RGD:5688289
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Cacna1d
calcium channel, voltage-dependent, L type, alpha 1D subunit
susceptibility
ISO
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412
G
Drd2
dopamine receptor D2
susceptibility
ISO
DNA:SNP:exon:A>G(human)
RGD
PMID:23238469
RGD:401959213
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Pdyn
prodynorphin
IEP
mRNA:increased expression:brain
RGD
PMID:15869750
RGD:401850576
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Slc29a1
solute carrier family 29 (nucleoside transporters), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Aif1
allograft inflammatory factor 1
ISO
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Cirbp
cold inducible RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr10:80,001,824...80,008,620
Ensembl chr10:80,001,819...80,008,620
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:100,297,855...100,304,479
Ensembl chr X:100,298,134...100,304,479
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr 5:121,357,323...121,506,633
Ensembl chr 5:121,358,282...121,506,640
G
Ank3
ankyrin 3, epithelial
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:14,956,405...15,051,085
Ensembl chr 8:14,961,663...15,051,085
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2
insulin-like growth factor 2
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
ISO
RGD
PMID:18093169
RGD:408345248
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Akap9
A kinase anchor protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:3,977,410...4,130,204
Ensembl chr 5:3,978,054...4,131,310
G
Alad
aminolevulinate, delta-, dehydratase
ISO
protein:decreased activity:blood (rat)
RGD
PMID:19022878
RGD:4144202
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19805235
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
As3mt
arsenite methyltransferase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21447609 PMID:26366667 PMID:35226250
NCBI chr19:46,695,124...46,729,538
Ensembl chr19:46,695,897...46,729,538
G
Atxn7
ataxin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:8,358,358...8,508,324
Ensembl chr14:8,362,461...8,508,323
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccrl2
C-C motif chemokine receptor-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:110,883,902...110,886,586
Ensembl chr 9:110,883,554...110,886,587
G
Cd44
CD44 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cd83
CD83 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:skin:
RGD
PMID:11860939
RGD:8662429
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Crp
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22521605
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Ercc3
excision repair cross-complementing rodent repair deficiency, complementation group 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204
G
Ercc4
excision repair cross-complementing rodent repair deficiency, complementation group 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr16:12,927,600...12,969,873
Ensembl chr16:12,927,548...12,968,481
G
Gadd45b
growth arrest and DNA-damage-inducible 45 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
G
Golga4
golgin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:118,335,280...118,411,587
Ensembl chr 9:118,335,335...118,411,587
G
Gsr
glutathione reductase
ISO
RGD
PMID:25209654
RGD:10401880
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hspa1b
heat shock protein 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Id2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
G
Ier3
immediate early response 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr16:21,877,759...21,982,049
Ensembl chr16:21,877,759...21,982,049
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Inpp5a
inositol polyphosphate-5-phosphatase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25759212
NCBI chr 7:138,969,025...139,159,568
Ensembl chr 7:138,969,025...139,159,568
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:110,956,990...110,967,651
Ensembl chr11:110,956,990...110,967,647
G
Krt10
keratin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19953893
NCBI chr11:99,276,080...99,288,631
Ensembl chr11:99,276,080...99,280,190
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr 3:123,161,944...123,179,639
Ensembl chr 3:123,161,946...123,179,757
G
Minpp1
multiple inositol polyphosphate histidine phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr19:32,463,169...32,492,770
Ensembl chr19:32,463,169...32,492,764
G
Mir145a
microRNA 145a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29705342
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
G
Mir155
microRNA 155
ISO
miRNA:increased expression:serum
RGD
PMID:27913196
RGD:25314296
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24384392
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
N4bp2l2
NEDD4 binding protein 2-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:150,515,310...150,589,213
Ensembl chr 5:150,531,472...150,589,648
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015
G
Pde4b
phosphodiesterase 4B, cAMP specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Peli1
pellino 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:21,041,283...21,100,327
Ensembl chr11:21,041,291...21,100,323
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888
G
Pias1
protein inhibitor of activated STAT 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:62,785,648...62,888,161
Ensembl chr 9:62,785,650...62,895,206
G
Pnp2
purine-nucleoside phosphorylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414634
NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
G
Ptx3
pentraxin related gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:66,127,308...66,133,227
Ensembl chr 3:66,127,331...66,133,226
G
Rfx3
regulatory factor X, 3 (influences HLA class II expression)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr19:27,739,121...27,995,287
Ensembl chr19:27,739,121...27,988,566
G
Rgs1
regulator of G-protein signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:144,120,407...144,124,862
Ensembl chr 1:144,118,034...144,124,980
G
Rnf20
ring finger protein 20
ISO
protein:increased expression:urine (human)
RGD
PMID:21136906
RGD:9831407
NCBI chr 4:49,632,005...49,656,887
Ensembl chr 4:49,632,006...49,656,887
G
Rufy3
RUN and FYVE domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:88,711,305...88,799,276
Ensembl chr 5:88,712,899...88,799,251
G
Sfpq
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:126,914,504...126,944,894
Ensembl chr 4:126,915,117...126,930,806
G
Skil
SKI-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:31,149,259...31,176,741
Ensembl chr 3:31,149,207...31,176,726
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sox18
SRY (sex determining region Y)-box 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:181,311,630...181,313,433
Ensembl chr 2:181,311,629...181,313,433
G
Srp68
signal recognition particle 68
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:116,135,992...116,165,043
Ensembl chr11:116,135,992...116,165,043
G
Ssbp1
single-stranded DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:40,448,302...40,458,757
Ensembl chr 6:40,448,286...40,461,634
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I, D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:15,217,485...15,228,293
Ensembl chr 9:15,217,510...15,228,287
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip6
tumor necrosis factor alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
G
Tnik
TRAF2 and NCK interacting kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:28,317,362...28,724,734
Ensembl chr 3:28,317,363...28,730,007
G
Tra2a
transformer 2 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:49,220,855...49,241,182
Ensembl chr 6:49,220,858...49,240,967
G
Trappc10
trafficking protein particle complex 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:78,021,256...78,080,479
Ensembl chr10:78,022,559...78,080,475
G
Trp53
transformation related protein 53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18621066 PMID:19203779
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:4,137,852...4,186,967
Ensembl chr14:4,137,837...4,186,974
G
Uso1
USO1 vesicle docking factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:92,285,770...92,350,659
Ensembl chr 5:92,285,797...92,350,657
G
Usp13
ubiquitin specific peptidase 13 (isopeptidase T-3)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:32,870,432...32,992,224
Ensembl chr 3:32,871,695...32,992,220
G
Zfand6
zinc finger, AN1-type domain 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 7:84,264,253...84,339,224
Ensembl chr 7:84,262,974...84,339,167
G
Zfp267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:36,205,233...36,224,491
Ensembl chr 3:36,205,166...36,224,491
G
Ache
acetylcholinesterase
treatment
ISO
RGD
PMID:27491636
RGD:152995409
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Ada
adenosine deaminase
treatment
ISO
RGD
PMID:27491636
RGD:152995409
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Cpa1
carboxypeptidase A1, pancreatic
ISO
protein:increased activity:small intestine (rat)
RGD
PMID:15865404
RGD:1578424
NCBI chr 6:30,639,217...30,645,360
Ensembl chr 6:30,639,217...30,645,362
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:plasma:
RGD
PMID:24361405
RGD:9685430
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Gpx1
glutathione peroxidase 1
treatment
ISO
RGD
PMID:24954678
RGD:11352769
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx4
glutathione peroxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643113
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24200859
RGD:10401881
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Htt
huntingtin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19845833
NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878
G
Il6
interleukin 6
ISO
in males;protein:increased expression, increased activity:plasma (rat)
RGD
PMID:19462680
RGD:11060270
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Mt3
metallothionein 3
IAGP
RGD
PMID:20371971
RGD:6480494
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Nudt1
nudix hydrolase 1
ISO
RGD
PMID:11817101
RGD:633232
NCBI chr 5:140,307,375...140,323,892
Ensembl chr 5:140,307,411...140,323,892
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643113
NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
ISO
RGD
PMID:24704181
RGD:151347543
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:20422170 PMID:19520142
RGD:4145288 , RGD:4145306
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Mbp
myelin basic protein
ISO
protein:decreased expression:brain:
RGD
PMID:23146304
RGD:7327205
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
Nos1
nitric oxide synthase 1, neuronal
IMP
RGD
PMID:14761684
RGD:13825130
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Xdh
xanthine dehydrogenase
ISO
RGD
PMID:17433579 PMID:8248931
RGD:13209022 , RGD:13210748
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Fadd
Fas associated via death domain
treatment
ISO
RGD
PMID:25687490
RGD:11341810
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
G
Gfer
growth factor, augmenter of liver regeneration
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15968720
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Gpx1
glutathione peroxidase 1
ISO
RGD
PMID:18306454
RGD:2312624
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx2
glutathione peroxidase 2
treatment
ISO
RGD
PMID:31018559
RGD:401827907
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:31018559 PMID:18306454
RGD:401827907 , RGD:2312624
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:24748974
RGD:10755718
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:23684718
RGD:11035220
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Ucp2
uncoupling protein 2 (mitochondrial, proton carrier)
ISO
protein:increased expression:liver
RGD
PMID:19104935
RGD:7204431
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
G
Aass
aminoadipate-semialdehyde synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
G
Abcb11
ATP-binding cassette, sub-family B member 11
severity
ISO
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
severity susceptibility
IMP ISO EXP
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832
RGD:11041130 , RGD:14700895
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27193730
NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
G
Abcc1
ATP-binding cassette, sub-family C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Abcc2
ATP-binding cassette, sub-family member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human)
CTD RGD
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354
RGD:14700814 , RGD:14700812
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abi1
abl interactor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:22,830,085...22,930,207
Ensembl chr 2:22,830,085...22,930,253
G
Ace
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25143335
RGD:25671447
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acox3
acyl-Coenzyme A oxidase 3, pristanoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:35,740,293...35,772,397
Ensembl chr 5:35,740,384...35,772,696
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
G
Actb
actin, beta
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:22563491
RGD:9587759
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765
G
Actr3
ARP3 actin-related protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:125,320,642...125,363,464
Ensembl chr 1:125,320,642...125,363,464
G
Ada
adenosine deaminase
ISO
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Adam8
a disintegrin and metallopeptidase domain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
severity
ISO
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adora2b
adenosine A2b receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Ahr
aryl-hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:34848246 PMID:28959666
RGD:401794432
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Aifm1
apoptosis-inducing factor, mitochondrion-associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
G
Ak4
adenylate kinase 4
ISO
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
G
Akr1a1
aldo-keto reductase family 1, member A1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32805337 PMID:29763686
RGD:27226688
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Alb
albumin
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:83,320,386...83,370,008
Ensembl chr10:83,323,314...83,370,004
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
severity susceptibility
ISO IMP
protein:increased expression:liver DNA:deletion:exon 3 (mouse)
RGD
PMID:21138988 PMID:30121625 PMID:24492981
RGD:7241599 , RGD:15036810 , RGD:14975148
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh9a1
aldehyde dehydrogenase 9, subfamily A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:167,177,560...167,196,100
Ensembl chr 1:167,177,560...167,196,101
G
Aldob
aldolase B, fructose-bisphosphate
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546
G
Ambp
alpha 1 microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Anxa6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
G
Apoa1
apolipoprotein A-I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Apoh
apolipoprotein H
ISO
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
G
Arg1
arginase, liver
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
G
Atg5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
G
Atoh8
atonal bHLH transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:72,183,158...72,212,765
Ensembl chr 6:72,183,161...72,212,561
G
Atp6v1d
ATPase, H+ transporting, lysosomal V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:78,889,756...78,908,810
Ensembl chr12:78,887,499...78,908,412
G
Avp
arginine vasopressin
ISO
DNA:SNP:intron: (rs2282018)
RGD
PMID:28462386
RGD:408364979
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
Bad
BCL2-associated agonist of cell death
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bdh1
3-hydroxybutyrate dehydrogenase, type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:31,241,115...31,277,719
Ensembl chr16:31,241,098...31,277,719
G
Bdkrb2
bradykinin receptor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
Blvrb
biliverdin reductase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:27,147,403...27,165,406
Ensembl chr 7:27,147,403...27,165,569
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:185,061,619...185,089,974
Ensembl chr 1:185,064,346...185,089,974
G
Brd4
bromodomain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696
G
Btd
biotinidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chr14:31,363,014...31,390,154
Ensembl chr14:31,362,985...31,390,536
G
C3
complement component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cabp1
calcium binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr 5:115,306,750...115,332,440
Ensembl chr 5:115,306,748...115,332,440
G
Cadps2
Ca2+-dependent activator protein for secretion 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 6:23,262,765...23,840,662
Ensembl chr 6:23,262,772...23,839,420
G
Canx
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:50,184,784...50,216,500
Ensembl chr11:50,184,788...50,216,500
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
G
Car3
carbonic anhydrase 3
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cast
calpastatin
ISO
RGD
PMID:16871587
RGD:5683869
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:20623750 PMID:25231249 PMID:21138988
RGD:7241599
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccdc80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:44,913,770...44,948,287
Ensembl chr16:44,913,765...44,948,440
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:21813474 PMID:30663942
RGD:14995466 , RGD:14995458
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr5
C-C motif chemokine receptor 5
susceptibility
IMP
acetaminophen
RGD
PMID:24770590
RGD:14401733
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cct3
chaperonin containing TCP1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:88,204,442...88,229,073
Ensembl chr 3:88,204,423...88,229,074
G
Cct5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950
G
Cdc25b
cell division cycle 25B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:101,913,001...101,971,724
Ensembl chr 5:101,912,996...101,971,724
G
Cela1
chymotrypsin-like elastase family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:100,572,303...100,585,801
Ensembl chr15:100,572,302...100,585,802
G
Cfap20
cilia and flagella associated protein 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:96,146,867...96,161,716
Ensembl chr 8:96,146,877...96,161,497
G
Cfh
complement component factor h
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Chrm3
cholinergic receptor, muscarinic 3, cardiac
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
G
Ckb
creatine kinase, brain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Col14a1
collagen, type XIV, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:55,171,040...55,384,199
Ensembl chr15:55,171,146...55,384,199
G
Col3a1
collagen, type III, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Comt
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Coq9
coenzyme Q9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:95,565,041...95,581,523
Ensembl chr 8:95,564,949...95,581,523
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Cpb2
carboxypeptidase B2
ISO
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995
G
Cps1
carbamoyl-phosphate synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Crp
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf3
colony stimulating factor 3 (granulocyte)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20005281 PMID:33882750
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Ctse
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38614205
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
IEP
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
EXP ISO
CTD Direct Evidence: therapeutic CTD Direct Evidence: marker/mechanism
CTD
PMID:21741958 PMID:23628428
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043 PMID:33814510
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12963435 PMID:28762043
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2c52-ps
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
DNA:hypermethylation:promoter
RGD
PMID:27490558
RGD:14700879
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia
CTD RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 PMID:27490558 PMID:27324775 PMID:29404441 PMID:25681370 More...
RGD:14700901 , RGD:14700879 , RGD:14700878 , RGD:14700873 , RGD:14700872
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Dbt
dihydrolipoamide branched chain transacylase E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:116,306,776...116,343,630
Ensembl chr 3:116,306,719...116,343,630
G
Ddb1
damage specific DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:10,582,961...10,607,186
Ensembl chr19:10,582,691...10,607,183
G
Dgat2
diacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
G
Dhfr
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Dhrs7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683
G
Dlat
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:50,545,933...50,571,080
Ensembl chr 9:50,545,933...50,571,080
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr10:63,218,222...63,244,619
Ensembl chr10:63,218,222...63,246,355
G
Dsc2
desmocollin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
G
E2f1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Echdc1
enoyl Coenzyme A hydratase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:29,174,140...29,222,657
Ensembl chr10:29,189,162...29,223,465
G
Echs1
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
G
Edem1
ER degradation enhancer, mannosidase alpha-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chr 5:143,803,586...143,839,535
Ensembl chr 5:143,803,543...143,841,069
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:61,268,276...61,288,448
Ensembl chr10:61,264,270...61,288,440
G
Endog
endonuclease G
ISO
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chr 2:30,061,525...30,064,057
Ensembl chr 2:30,061,505...30,064,081
G
Eng
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
G
Eno1
enolase 1, alpha non-neuron
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Ephx1
epoxide hydrolase 1, microsomal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Erlec1
endoplasmic reticulum lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr11:30,812,794...30,904,385
Ensembl chr11:30,880,774...30,904,335
G
Ern1
endoplasmic reticulum to nucleus signalling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
F13a1
coagulation factor XIII, A1 subunit
IMP
RGD
PMID:22019897
RGD:11041813
NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
G
F2rl3
F2R like thrombin or trypsin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 8:73,488,287...73,490,526
Ensembl chr 8:73,488,508...73,490,502
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fadd
Fas associated via death domain
treatment
ISO
RGD
PMID:26062544 PMID:25447754
RGD:11341803 , RGD:10053709
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
G
Fads1
fatty acid desaturase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:10,160,245...10,174,238
Ensembl chr19:10,160,252...10,174,241
G
Fads2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:liver (rat)
RGD
PMID:16831245
RGD:8662853
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fcmr
Fc fragment of IgM receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:130,793,514...130,808,528
Ensembl chr 1:130,793,406...130,808,528
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fgf21
fibroblast growth factor 21
severity
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914
G
Flt1
FMS-like tyrosine kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Fmo3
flavin containing monooxygenase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24973094
NCBI chr 1:162,781,368...162,812,097
Ensembl chr 1:162,781,369...162,812,097
G
Ftl1
ferritin light polypeptide 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
IEP
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
treatment
ISO
RGD
PMID:21864513
RGD:10449168
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Ganab
alpha glucosidase 2 alpha neutral subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:8,875,440...8,894,098
Ensembl chr19:8,875,435...8,894,036
G
Gc
vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19481141 PMID:17573345
RGD:10402383
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:21,368,671...21,450,025
Ensembl chr19:21,368,671...21,450,809
G
Gdi1
GDP dissociation inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:73,348,618...73,355,473
Ensembl chr X:73,348,604...73,355,468
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO
RGD
PMID:22033404 PMID:15968720
RGD:9685722 , RGD:9685727
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chr 4:20,041,963...20,066,111
Ensembl chr 4:20,042,052...20,066,750
G
Ggt1
gamma-glutamyltransferase 1
ISO
RGD
PMID:10934156
RGD:14701049
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Ghrl
ghrelin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34151639
NCBI chr 6:113,693,080...113,696,872
Ensembl chr 6:113,693,080...113,696,841
G
Glud1
glutamate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gpd1
glycerol-3-phosphate dehydrogenase 1 (soluble)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum:
CTD RGD
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 PMID:21772750 PMID:28487901 More...
RGD:14975249 , RGD:14975249 , RGD:14975168 , RGD:14975166 , RGD:14975162
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpt2
glutamic pyruvate transaminase (alanine aminotransferase) 2
ISO IEP
protein:increased expression, activity:serum:
RGD
PMID:19085960 PMID:19085960
RGD:14975249 , RGD:14975249
NCBI chr 8:86,219,090...86,255,531
Ensembl chr 8:86,219,205...86,254,189
G
Grk4
G protein-coupled receptor kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:34,817,641...34,912,649
Ensembl chr 5:34,817,723...34,912,649
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Gsr
glutathione reductase
treatment
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663
RGD:7257532 , RGD:10401878
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm1
glutathione S-transferase, mu 1
no_association
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 PMID:29523098 PMID:21138988 More...
RGD:14700970 , RGD:14700959 , RGD:14700941 , RGD:14700937 , RGD:7241599
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstm2
glutathione S-transferase, mu 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
G
Gstm4
glutathione S-transferase, mu 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
G
Gstm5
glutathione S-transferase, mu 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
G
Gsto1
glutathione S-transferase omega 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229
G
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18397238 PMID:18666253 PMID:25226513
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gulo
gulonolactone (L-) oxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:66,224,235...66,246,703
Ensembl chr14:66,224,235...66,246,656
G
H19
H19, imprinted maternally expressed transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,133,957
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphism: :HLA-DQA1*0102(human) associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD
PMID:20639878 PMID:12359646
RGD:14398844 , RGD:14401573
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*05(human) DNA:polymorphism, haplotype
CTD RGD
PMID:21570397 PMID:25250564 PMID:26959717
RGD:36174016 , RGD:11573514
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Eb1
histocompatibility 2, class II antigen E beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-M2
histocompatibility 2, M region locus 2
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
CTD ClinVar
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 PMID:15247625 PMID:18256392 PMID:19483685 More...
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-Q1
histocompatibility 2, Q region locus 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397 PMID:28043905
NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:23265463
RGD:8693741
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Hacl1
2-hydroxyacyl-CoA lyase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:31,329,183...31,364,201
Ensembl chr14:31,320,687...31,363,243
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hao2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hba-a1
hemoglobin alpha, adult chain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:32,233,672...32,234,486
Ensembl chr11:32,233,511...32,234,465
G
Hmgb1
high mobility group box 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmox1
heme oxygenase 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 , RGD:15090820
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hpd
4-hydroxyphenylpyruvic acid dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chr 5:123,309,870...123,320,786
Ensembl chr 5:123,309,870...123,320,790
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hpx
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
G
Hrh2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chr13:54,345,990...54,390,201
Ensembl chr13:54,346,148...54,390,199
G
Hspa5
heat shock protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspa8
heat shock protein 8
ISO
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:29091898
RGD:15090820
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
severity
IMP
RGD
PMID:31121248
RGD:14985250
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Ido2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
G
Ifna2
interferon alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1670585
NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149
G
Ifng
interferon gamma
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Il11
interleukin 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chr 7:4,775,372...4,785,877
Ensembl chr 7:4,775,372...4,785,858
G
Il12b
interleukin 12b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 PMID:31077717 PMID:29278859 More...
RGD:7204421 , RGD:15090820 , RGD:15036799 , RGD:14975281 , RGD:13793380
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1r2
interleukin 1 receptor, type II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391
G
Il22b
interleukin 22B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chr10:118,125,534...118,130,943
Ensembl chr10:118,125,534...118,130,943
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Immt
inner membrane protein, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:71,806,200...71,852,250
Ensembl chr 6:71,808,315...71,854,372
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
G
Itpr1
inositol 1,4,5-trisphosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
G
Jund
jun D proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Keap1
kelch-like ECH-associated protein 1
IMP
RGD
PMID:18417483
RGD:6893370
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Kitl
kit ligand
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828
G
Krt18
keratin 18
IEP ISO
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:33483742 PMID:38521541 PMID:17340120
RGD:18337498
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Lap3
leucine aminopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:45,650,716...45,670,033
Ensembl chr 5:45,650,716...45,670,033
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcat
lecithin cholesterol acyltransferase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:20623750
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Lgals3
lectin, galactose binding, soluble 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lipc
lipase, hepatic
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 9:70,705,410...70,859,503
Ensembl chr 9:70,705,410...70,859,508
G
Lpl
lipoprotein lipase
treatment
ISO
RGD
PMID:27071702
RGD:13794380
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
G
Lrat
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280
G
Ltb4r1
leukotriene B4 receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chr14:56,002,154...56,005,951
Ensembl chr14:56,003,419...56,005,951
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Malat1
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,853,602
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Mat1a
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:40,826,969...40,846,385
Ensembl chr14:40,826,992...40,846,369
G
Mccc1
methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:36,009,584...36,054,843
Ensembl chr 3:36,013,461...36,054,827
G
Mdh1
malate dehydrogenase 1, NAD (soluble)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr11:21,506,692...21,521,934
Ensembl chr11:21,506,692...21,522,367
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Med1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119
G
Mir100
microRNA 100
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:41,442,721...41,442,800
Ensembl chr 9:41,442,721...41,442,800
G
Mir103-1
microRNA 103-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr11:35,673,223...35,673,308
Ensembl chr11:35,673,223...35,673,308
G
Mir106b
microRNA 106b
IEP IDA
miRNA:decreased expression:liver (rat) DNA:hypermethylation:promoter
RGD
PMID:29554950 PMID:29554950
RGD:15042854 , RGD:15042854
NCBI chr 5:138,163,999...138,164,080
Ensembl chr 5:138,163,999...138,164,080
G
Mir107
microRNA 107
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr19:34,798,087...34,798,173
Ensembl chr19:34,798,087...34,798,173
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr11:96,207,991...96,208,100
Ensembl chr11:96,207,991...96,208,100
G
Mir10b
microRNA 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 2:74,556,414...74,556,481
Ensembl chr 2:74,556,414...74,556,481
G
Mir122
microRNA 122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 PMID:33483742 More...
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir1247
microRNA 1247
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:110,244,482...110,244,563
Ensembl chr12:110,244,482...110,244,563
G
Mir1249
microRNA 1249
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:84,835,727...84,835,824
Ensembl chr15:84,835,727...84,835,824
G
Mir125b-1
microRNA 125b-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:41,493,222...41,493,298
Ensembl chr 9:41,493,222...41,493,298
G
Mir125b-2
microRNA 125b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:77,443,161...77,443,231
Ensembl chr16:77,443,161...77,443,231
G
Mir1291
microRNA 1291
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:98,417,643...98,417,759
Ensembl chr15:98,417,643...98,417,759
G
Mir1306
microRNA 1306
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:18,102,103...18,102,181
Ensembl chr16:18,102,103...18,102,181
G
Mir130a
microRNA 130a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 2:84,571,459...84,571,522
Ensembl chr 2:84,571,459...84,571,522
G
Mir130b
microRNA 130b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:16,941,925...16,942,006
Ensembl chr16:16,941,925...16,942,006
G
Mir132
microRNA 132
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr11:75,064,508...75,064,573
Ensembl chr11:75,064,508...75,064,573
G
Mir141
microRNA 141
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
G
Mir148a
microRNA 148a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 6:51,246,792...51,246,890
Ensembl chr 6:51,246,792...51,246,890
G
Mir149
microRNA 149
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:92,778,100...92,778,165
Ensembl chr 1:92,778,100...92,778,165
G
Mir150
microRNA 150
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:44,771,181...44,771,245
Ensembl chr 7:44,771,181...44,771,245
G
Mir152
microRNA 152
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir155
microRNA 155
treatment
IMP IDA
RGD
PMID:29420849 PMID:26867493 PMID:27673475
RGD:21409750 , RGD:25671474 , RGD:25671463
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir17
microRNA 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir18
microRNA 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:115,281,283...115,281,378
Ensembl chr14:115,281,283...115,281,378
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 8:84,905,502...84,905,590
Ensembl chr 8:84,905,502...84,905,590
G
Mir188
microRNA 188
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:7,114,228...7,114,295
Ensembl chr X:7,114,228...7,114,295
G
Mir191
microRNA 191
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:108,445,518...108,445,591
Ensembl chr 9:108,445,518...108,445,591
G
Mir192
microRNA 192
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106
NCBI chr19:6,314,874...6,314,962
Ensembl chr19:6,314,874...6,314,962
G
Mir193a
microRNA 193a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:79,602,795...79,602,860
Ensembl chr11:79,602,795...79,602,860
G
Mir193b
microRNA 193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,267,387...13,267,465
Ensembl chr16:13,267,387...13,267,465
G
Mir194-1
microRNA 194-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28844483
NCBI chr 1:185,045,516...185,045,582
Ensembl chr 1:185,045,516...185,045,582
G
Mir19a
microRNA 19a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:115,281,432...115,281,513
Ensembl chr14:115,281,432...115,281,513
G
Mir1a-1
microRNA 1a-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr 2:180,030,841...180,030,917
Ensembl chr 2:180,030,841...180,030,917
G
Mir200c
microRNA 200c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 6:124,695,285...124,695,353
Ensembl chr 6:124,695,285...124,695,353
G
Mir203
microRNA 203
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:32659284
NCBI chr12:112,097,314...112,097,389
Ensembl chr12:112,097,314...112,097,389
G
Mir210
microRNA 210
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:140,801,297...140,801,406
Ensembl chr 7:140,801,297...140,801,406
G
Mir217
microRNA 217
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr11:28,713,728...28,713,835
Ensembl chr11:28,713,728...28,713,835
G
Mir218-1
microRNA 218-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:30125006
NCBI chr 5:48,381,284...48,381,393
Ensembl chr 5:48,381,284...48,381,393
G
Mir21a
microRNA 21a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir22
microRNA 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:19,012,533...19,012,627
Ensembl chr X:19,012,533...19,012,627
G
Mir222
microRNA 222
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:19,013,132...19,013,210
Ensembl chr X:19,013,132...19,013,210
G
Mir223
microRNA 223
IEP
RNA:increased expression:serum,liver
RGD
PMID:28646120
RGD:21408574
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir23a
microRNA 23a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:84,935,147...84,935,221
Ensembl chr 8:84,935,147...84,935,221
G
Mir23b
microRNA 23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371
G
Mir27b
microRNA 27b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr13:63,448,526...63,448,598
Ensembl chr13:63,448,526...63,448,598
G
Mir29b-2
microRNA 29b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:194,719,348...194,719,428
Ensembl chr 1:194,719,348...194,719,428
G
Mir29c
microRNA 29c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30515189
NCBI chr 1:194,719,855...194,719,942
Ensembl chr 1:194,719,855...194,719,942
G
Mir301
microRNA 301
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:87,003,830...87,003,915
Ensembl chr11:87,003,830...87,003,915
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:25359176 PMID:28545106
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:68,209,264...68,209,359
Ensembl chr15:68,209,264...68,209,359
G
Mir30c-1
microRNA 30c-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:120,626,731...120,626,819
Ensembl chr 4:120,626,731...120,626,819
G
Mir320
microRNA 320
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
Mir327
microRNA 327
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:45,184,900...45,184,968
Ensembl chr14:45,184,900...45,184,968
G
Mir328
microRNA 328
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:106,034,996...106,035,092
Ensembl chr 8:106,034,996...106,035,092
G
Mir335
microRNA 335
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:30,741,298...30,741,395
Ensembl chr 6:30,741,298...30,741,395
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr12:109,552,223...109,552,319
Ensembl chr12:109,552,223...109,552,319
G
Mir338
microRNA 338
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688
G
Mir342
microRNA 342
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:108,624,879...108,624,977
Ensembl chr12:108,624,879...108,624,977
G
Mir345
microRNA 345
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:108,802,899...108,802,994
Ensembl chr12:108,802,899...108,802,994
G
Mir34a
microRNA 34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
G
Mir34c
microRNA 34c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 9:51,014,334...51,014,410
Ensembl chr 9:51,014,334...51,014,410
G
Mir351
microRNA 351
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:52,142,132...52,142,230
Ensembl chr X:52,142,132...52,142,230
G
Mir361
microRNA 361
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:111,984,521...111,984,590
Ensembl chr X:111,984,521...111,984,590
G
Mir362
microRNA 362
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:7,108,221...7,108,285
Ensembl chr X:7,108,221...7,108,285
G
Mir367
microRNA 367
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 3:127,339,382...127,339,456
Ensembl chr 3:127,339,382...127,339,456
G
Mir378a
microRNA 378a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr18:61,530,906...61,530,971
Ensembl chr18:61,530,906...61,530,971
G
Mir410
microRNA 410
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr12:109,710,149...109,710,229
Ensembl chr12:109,710,149...109,710,229
G
Mir421
microRNA 421
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:102,616,527...102,616,602
Ensembl chr X:102,616,527...102,616,602
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir452
microRNA 452
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:71,305,830...71,305,914
Ensembl chr X:71,305,830...71,305,914
G
Mir455
microRNA 455
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 4:63,175,088...63,175,169
Ensembl chr 4:63,175,088...63,175,169
G
Mir483
microRNA 483
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,977,490...13,977,556
Ensembl chr16:13,977,490...13,977,556
G
Mir497
microRNA 497
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:70,125,543...70,125,626
Ensembl chr11:70,125,543...70,125,626
G
Mir499
microRNA 499
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 2:155,464,800...155,464,878
Ensembl chr 2:155,464,800...155,464,878
G
Mir503
microRNA 503
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:52,142,861...52,142,931
Ensembl chr X:52,142,861...52,142,931
G
Mir505
microRNA 505
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:59,439,649...59,439,738
Ensembl chr X:59,439,649...59,439,738
G
Mir5099
microRNA 5099
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28844483
NCBI chr12:36,866,204...36,866,277
Ensembl chr12:36,866,204...36,866,277
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:7,114,641...7,114,736
Ensembl chr X:7,114,641...7,114,736
G
Mir574
microRNA 574
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:65,127,661...65,127,738
Ensembl chr 5:65,127,661...65,127,738
G
Mir592
microRNA 592
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr 6:27,936,654...27,936,749
Ensembl chr 6:27,936,654...27,936,749
G
Mir687
microRNA 687
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:73,444,203...73,444,291
Ensembl chr14:73,444,203...73,444,291
G
Mir697
microRNA 697
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:124,625,487...124,625,595
Ensembl chr 4:124,625,487...124,625,595
G
Mir704
microRNA 704
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 6:47,780,510...47,780,586
Ensembl chr 6:47,780,510...47,780,586
G
Mir744
microRNA 744
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr11:65,625,559...65,625,658
Ensembl chr11:65,625,559...65,625,658
G
Mir764
microRNA 764
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:145,785,255...145,785,362
Ensembl chr X:145,785,255...145,785,362
G
Mir877
microRNA 877
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27713024
NCBI chr17:36,271,622...36,271,706
Ensembl chr17:36,271,622...36,271,706
G
Mir879
microRNA 879
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 5:9,425,704...9,425,779
Ensembl chr 5:9,425,704...9,425,779
G
Mir93
microRNA 93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
G
Mir99a
microRNA 99a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:77,395,824...77,395,888
Ensembl chr16:77,395,824...77,395,888
G
Mirlet7b
microRNA let7b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr15:85,591,520...85,591,604
Ensembl chr15:85,591,520...85,591,604
G
Mirlet7c-1
microRNA let7c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638
G
Mirlet7d
microRNA let7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:48,689,488...48,689,590
Ensembl chr13:48,689,488...48,689,590
G
Mirlet7g
microRNA let7g
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:106,056,039...106,056,126
Ensembl chr 9:106,056,039...106,056,126
G
Mirlet7i
microRNA let7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:122,821,545...122,821,629
Ensembl chr10:122,821,545...122,821,629
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mst1
macrophage stimulating 1 (hepatocyte growth factor-like)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:107,957,607...107,962,226
Ensembl chr 9:107,957,635...107,962,202
G
Mst1r
macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chr 9:107,784,057...107,797,582
Ensembl chr 9:107,784,072...107,797,582
G
mt-Nd6
NADH dehydrogenase 6, mitochondrial
ISO
mRNA:decreased expression:blood
RGD
PMID:20130021
RGD:8657129
NCBI chr MT:13,552...14,070
Ensembl chr MT:13,552...14,070
G
Mthfr
methylenetetrahydrofolate reductase
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD RGD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Mtpn
myotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:35,485,759...35,516,823
Ensembl chr 6:35,485,841...35,516,823
G
Myd88
myeloid differentiation primary response gene 88
ameliorates
IMP
RGD
PMID:17615358
RGD:150521532
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
treatment
ISO
associated with Tuberculosis;DNA:haplotype: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090
RGD:8552665
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:90,724,971...90,735,065
Ensembl chr 2:90,724,978...90,735,171
G
Nfatc4
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chr14:56,062,252...56,071,400
Ensembl chr14:56,060,601...56,071,400
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
IMP ISO IEP
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) CTD Direct Evidence: therapeutic
CTD RGD
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 PMID:18417483 PMID:31889292 PMID:31927046 PMID:32066295 PMID:31972209 PMID:29091898 More...
RGD:6893370 , RGD:21201308 , RGD:21201305 , RGD:21201283 , RGD:21201280 , RGD:15090820
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
treatment susceptibility
IEP ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 , RGD:40902984
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfxl1
nuclear transcription factor, X-box binding-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 5:72,670,647...72,717,078
Ensembl chr 5:72,670,644...72,717,027
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085
G
Notch1
notch 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
G
Nox4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO IEP
RGD
PMID:28522909 PMID:29091898 PMID:28472605
RGD:13439737 , RGD:15090820 , RGD:13439739
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
treatment
IDA
RGD
PMID:24497272
RGD:10448995
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment severity
ISO IEP IMP
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (rat) protein:decreased expression:liver (rat)
CTD RGD
PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 PMID:20573685 More...
RGD:15090820 , RGD:15045609 , RGD:15042870 , RGD:14701036 , RGD:14701035
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD RGD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186
G
Nrep
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Ntn1
netrin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr11:68,100,190...68,277,652
Ensembl chr11:68,100,190...68,291,649
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chr10:52,293,643...52,316,288
Ensembl chr10:52,293,643...52,316,279
G
Oas1a
2'-5' oligoadenylate synthetase 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 5:121,034,319...121,045,588
Ensembl chr 5:121,034,319...121,045,584
G
Ociad1
OCIA domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:73,450,093...73,471,420
Ensembl chr 5:73,450,127...73,471,412
G
Ogdh
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
G
Or51e2
olfactory receptor family 51 subfamily E member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
G
P4hb
prolyl 4-hydroxylase, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
G
Pah
phenylalanine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998
G
Pan2
PAN2 poly(A) specific ribonuclease subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr10:128,135,106...128,157,227
Ensembl chr10:128,139,204...128,157,227
G
Panx1
pannexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chr 9:14,917,081...14,956,774
Ensembl chr 9:14,913,424...14,956,774
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Pcolce
procollagen C-endopeptidase enhancer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:137,603,369...137,609,666
Ensembl chr 5:137,603,365...137,612,046
G
Pcx
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pcyt1a
phosphate cytidylyltransferase 1, choline, alpha isoform
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:32,249,739...32,293,883
Ensembl chr16:32,249,739...32,293,888
G
Pdk4
pyruvate dehydrogenase kinase, isoenzyme 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
G
Pdlim5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:141,945,346...142,101,480
Ensembl chr 3:141,945,351...142,101,454
G
Pex11a
peroxisomal biogenesis factor 11 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:79,385,705...79,392,879
Ensembl chr 7:79,385,705...79,392,879
G
Pgm1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plg
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Pls3
plastin 3 (T-isoform)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:74,829,259...74,918,788
Ensembl chr X:74,829,260...74,918,788
G
Pnp2
purine-nucleoside phosphorylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
G
Pnrc1
proline-rich nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163
G
Polg
polymerase (DNA directed), gamma
susceptibility no_association
ISO IAGP
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD RGD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039302 , RGD:15039297
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
Polr2g
polymerase (RNA) II (DNA directed) polypeptide G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:8,770,493...8,775,921
Ensembl chr19:8,770,491...8,775,941
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Ppara
peroxisome proliferator activated receptor alpha
IDA ISO
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24385052 PMID:38181850 PMID:21262334
RGD:5509941
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Pparg
peroxisome proliferator activated receptor gamma
IEP
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Pptc7
PTC7 protein phosphatase homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:122,422,461...122,462,344
Ensembl chr 5:122,422,428...122,462,344
G
Prkaa1
protein kinase, AMP-activated, alpha 1 catalytic subunit
treatment
IEP
RGD
PMID:29091898
RGD:15090820
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
G
Prkcd
protein kinase C, delta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
G
Prkdc
protein kinase, DNA activated, catalytic polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099
G
Ptf1a
pancreas specific transcription factor, 1a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chr 2:19,450,474...19,452,312
Ensembl chr 2:19,450,474...19,452,312
G
Ptges2
prostaglandin E synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31444509
NCBI chr 2:32,285,902...32,292,752
Ensembl chr 2:32,285,908...32,295,784
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pum1
pumilio RNA-binding family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:130,390,509...130,508,875
Ensembl chr 4:130,390,632...130,508,875
G
Pygl
liver glycogen phosphorylase
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:85,362,893...85,437,487
Ensembl chr13:85,362,899...85,437,249
G
Rbp1
retinol binding protein 1, cellular
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 9:98,305,014...98,328,604
Ensembl chr 9:98,305,014...98,328,628
G
Rdh13
retinol dehydrogenase 13 (all-trans and 9-cis)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 7:4,428,664...4,474,279
Ensembl chr 7:4,427,769...4,448,648
G
Reep5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr18:34,477,938...34,508,044
Ensembl chr18:34,477,938...34,507,123
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:20,413,980...20,428,328
Ensembl chr X:20,416,026...20,428,328
G
Ripk3
receptor-interacting serine-threonine kinase 3
ISO IEP
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse)
CTD RGD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
G
S100a11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
G
Scarb1
scavenger receptor class B, member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
G
Selenbp1
selenium binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 3:94,840,394...94,852,069
Ensembl chr 3:94,840,367...94,852,069
G
Sema3a
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chr 5:13,174,789...13,653,453
Ensembl chr 5:13,175,381...13,652,533
G
Sema4a
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chr 3:88,343,266...88,368,500
Ensembl chr 3:88,343,266...88,368,489
G
Senp2
SUMO/sentrin specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr16:21,828,182...21,868,019
Ensembl chr16:21,828,234...21,868,019
G
Serpina6
serine (or cysteine) peptidase inhibitor, clade A, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:103,612,889...103,623,477
Ensembl chr12:103,612,889...103,623,471
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Sesn2
sestrin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
G
Sgf29
SAGA complex associated factor 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:126,247,558...126,271,951
Ensembl chr 7:126,248,481...126,272,097
G
Shc1
src homology 2 domain-containing transforming protein C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chr 3:89,325,858...89,337,336
Ensembl chr 3:89,325,750...89,337,334
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc10a7
solute carrier family 10 (sodium/bile acid cotransporter family), member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 8:79,235,957...79,460,641
Ensembl chr 8:79,235,975...79,460,632
G
Slc13a4
solute carrier family 13 (sodium/sulfate symporters), member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:35,244,888...35,285,061
Ensembl chr 6:35,244,892...35,285,066
G
Slc22a8
solute carrier family 22 (organic anion transporter), member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
G
Slc25a29
solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:108,791,804...108,801,802
Ensembl chr12:108,791,799...108,801,809
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
treatment
ISO
RGD
PMID:9200186
RGD:151357001
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Snx18
sorting nexin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr13:113,728,715...113,755,100
Ensembl chr13:113,728,715...113,755,100
G
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
treatment severity susceptibility
ISO IMP
CTD Direct Evidence: marker/mechanism associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) DNA:SNP:cds:p.Val16Ala(human)
CTD RGD
PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157
RGD:11060605 , RGD:26923961 , RGD:26923959 , RGD:26923957
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sod3
superoxide dismutase 3, extracellular
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Sord
sorbitol dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chr 2:122,065,320...122,095,818
Ensembl chr 2:122,065,230...122,095,821
G
Sorl1
sortilin-related receptor, LDLR class A repeats-containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 9:41,876,005...42,035,593
Ensembl chr 9:41,876,016...42,035,593
G
Spin2c
spindlin family, member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr X:152,615,246...152,617,239
Ensembl chr X:152,615,221...152,617,239
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Srp72
signal recognition particle 72
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 5:77,122,548...77,147,782
Ensembl chr 5:77,122,530...77,147,784
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:38460807
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stat4
signal transducer and activator of transcription 4
severity
IEP
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:24731448 PMID:23876342
RGD:25671417 , RGD:25671422
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
G
Sult1c1
sulfotransferase family, cytosolic, 1C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:54,268,643...54,297,659
Ensembl chr17:54,268,643...54,297,702
G
Sult1e1
sulfotransferase family 1E, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Sult2b1
sulfotransferase family, cytosolic, 2B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chr 7:45,379,405...45,409,096
Ensembl chr 7:45,379,407...45,434,093
G
Suox
sulfite oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:128,505,756...128,509,787
Ensembl chr10:128,505,763...128,509,942
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
G
Taldo1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tctn1
tectonic family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 5:122,377,558...122,402,557
Ensembl chr 5:122,375,911...122,402,523
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:27516150
RGD:14995464
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Thpo
thrombopoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
G
Tlr4
toll-like receptor 4
disease_progression
ISO
RGD
PMID:17504260
RGD:14697733
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr5
toll-like receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
G
Tlr9
toll-like receptor 9
severity treatment
ISO IMP
protein:increased expression: blood, neutrophil (human)
RGD
PMID:26457748 PMID:19164858 PMID:23509352
RGD:18337465 , RGD:18337476 , RGD:18337473
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tmed7
transmembrane p24 trafficking protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr18:46,718,995...46,730,602
Ensembl chr18:46,693,302...46,730,602
G
Tmem117
transmembrane protein 117
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr15:94,527,066...94,993,978
Ensembl chr15:94,527,113...94,993,979
G
Tmem164
transmembrane protein 164
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:141,463,343...141,626,490
Ensembl chr X:141,464,402...141,626,490
G
Tmem38b
transmembrane protein 38B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:53,825,988...53,862,019
Ensembl chr 4:53,826,045...53,862,019
G
Tnf
tumor necrosis factor
treatment severity
ISO IEP IMP
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum (rat)
CTD RGD
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:37866487 PMID:15830285 PMID:29091898 PMID:31342809 PMID:14686721 PMID:10801288 PMID:10801287 PMID:19189285 PMID:17070847 PMID:31077717 PMID:11124822 More...
RGD:10450531 , RGD:15090820 , RGD:15036799 , RGD:14995485 , RGD:14995437 , RGD:14995435 , RGD:14995430 , RGD:14995429 , RGD:14975281 , RGD:14696804
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
IMP
RGD
PMID:24569808
RGD:9999438
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
G
Tuba1a
tubulin, alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584
G
Tubb4b
tubulin, beta 4B class IVB
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:25,112,170...25,114,714
Ensembl chr 2:25,112,172...25,114,714
G
Uba5
ubiquitin-like modifier activating enzyme 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 9:103,923,786...103,940,767
Ensembl chr 9:103,923,798...103,940,333
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
susceptibility
ISO
DNA:SNP:exon (rs4148323)(human)
RGD
PMID:28900877
RGD:14694824
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:3,985,222...3,999,340
Ensembl chr19:3,985,186...3,999,340
G
Usp5
ubiquitin specific peptidase 5 (isopeptidase T)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:124,791,982...124,806,404
Ensembl chr 6:124,791,982...124,806,447
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:17784864
RGD:15003197
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28527913 PMID:7531171
RGD:11079232
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wasl
WASP like actin nucleation promoting factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:24,613,809...24,665,185
Ensembl chr 6:24,613,804...24,665,008
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
susceptibility
IMP
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
G
Xylb
xylulokinase homolog (H. influenzae)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:119,186,447...119,222,863
Ensembl chr 9:119,186,447...119,222,863
G
Zdhhc23
zinc finger, DHHC domain containing 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:43,785,396...43,800,295
Ensembl chr16:43,785,396...43,800,154
G
Arrb2
arrestin, beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Gad1
glutamate decarboxylase 1
susceptibility
ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Gad2
glutamic acid decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr 2:22,512,262...22,583,889
Ensembl chr 2:22,512,217...22,583,886
G
Oprm1
opioid receptor, mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Abat
4-aminobutyrate aminotransferase
ISO
RGD
PMID:7740056 PMID:6445277
RGD:1598524 , RGD:10047091
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
G
Cacna1d
calcium channel, voltage-dependent, L type, alpha 1D subunit
ISO
RGD
PMID:18947822
RGD:6906919
NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19109989
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cck
cholecystokinin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2320253
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Comt
catechol-O-methyltransferase
ISO
RGD
PMID:16437585
RGD:2289781
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
RGD
PMID:12629505
RGD:1358549
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Dbn1
drebrin 1
ISO
levodopainduced; protein:increased expression:striatum:
RGD
PMID:23241013
RGD:10398811
NCBI chr13:55,621,241...55,635,874
Ensembl chr13:55,621,242...55,635,924
G
Ddc
dopa decarboxylase
ISO
associated with Parkinson Disease; protein:decreased expression:striatum (rat)
RGD
PMID:20232137
RGD:5128860
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801
RGD:2311579
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20945430
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Egr1
early growth response 1
ISO
RGD
PMID:22153973
RGD:10395307
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Fosb
FBJ osteosarcoma oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17219962
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Gad1
glutamate decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9767399
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gdnf
glial cell line derived neurotrophic factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11168568
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Glul
glutamate-ammonia ligase
ISO
RGD
PMID:6445277
RGD:10047091
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Grk6
G protein-coupled receptor kinase 6
ISO
associated with Parkinson Disease
RGD
PMID:20410529
RGD:5684919
NCBI chr13:55,592,865...55,608,740
Ensembl chr13:55,592,885...55,608,740
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:26997328
RGD:13792768
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Homer1
homer scaffolding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24126708
NCBI chr13:93,440,265...93,549,471
Ensembl chr13:93,436,143...93,541,637
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
RGD
PMID:21352823
RGD:5683628
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Mapt
microtubule-associated protein tau
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:25511986
RGD:13800920
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:23938307
RGD:10040953
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Pdyn
prodynorphin
treatment severity
ISO
CTD Direct Evidence: marker/mechanism associated with Parkinsonism associated with Parkinsonism;protein:increased expression:striatum
CTD RGD
PMID:9767399 PMID:21737418 PMID:10869049 PMID:17884291 PMID:21737418
RGD:401900134 , RGD:401851046 , RGD:401850563
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Penk
preproenkephalin
treatment disease_progression
ISO
mRNA:increased expression:brain:striatum: associated with Parkinsonism associated with Parkinsonism;mRNA:increased expression:striatum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9767399 PMID:20456008 PMID:10869049 PMID:26113400
RGD:10003039 , RGD:401900134 , RGD:401851054
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
G
Ppp1r1b
protein phosphatase 1, regulatory inhibitor subunit 1B
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:27771532
RGD:13514053
NCBI chr11:98,239,232...98,248,622
Ensembl chr11:98,239,230...98,248,622
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21115823
NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
protein:increased expression:nucleus, brain
RGD
PMID:18590723
RGD:2298778
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rgs4
regulator of G-protein signaling 4
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:24969021
RGD:13524515
NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18160641 PMID:24663062
NCBI chr11:109,116,174...109,189,013
Ensembl chr11:109,116,181...109,188,955
G
Th
tyrosine hydroxylase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Abcc2
ATP-binding cassette, sub-family member 2
susceptibility no_association
ISO
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple:
RGD
PMID:17502832 PMID:22178260
RGD:14700816 , RGD:14700817
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
ISO
RGD
PMID:16140414
RGD:2316848
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Lpar1
lysophosphatidic acid receptor 1
IEP
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898
G
Mir22
microRNA 22
IEP
in male; RNA:increased expression:liver:
RGD
PMID:21750200
RGD:14700876
NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636
G
Abcd1
ATP-binding cassette, sub-family D member 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,760,203...72,782,140
Ensembl chr X:72,760,203...72,782,140
G
Arhgap4
Rho GTPase activating protein 4
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,937,958...72,954,945
Ensembl chr X:72,935,048...72,965,476
G
Atp2b3
ATPase, Ca++ transporting, plasma membrane 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,546,356...72,632,267
Ensembl chr X:72,546,692...72,614,611
G
Atp6ap1
ATPase, H+ transporting, lysosomal accessory protein 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,340,753...73,348,297
Ensembl chr X:73,340,703...73,348,327
G
Avpr2
arginine vasopressin receptor 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,935,371...72,938,034
Ensembl chr X:72,935,708...72,939,108
G
Bcap31
B cell receptor associated protein 31
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,729,784...72,761,464
Ensembl chr X:72,729,784...72,759,781
G
Bgn
biglycan
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,527,207...72,539,542
Ensembl chr X:72,527,208...72,539,539
G
Brcc3
BRCA1/BRCA2-containing complex, subunit 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,460,234...74,499,307
Ensembl chr X:74,460,234...74,497,607
G
Ccnq
cyclin Q
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr11:78,641,332...78,642,555
Ensembl chr11:78,641,332...78,642,555
G
Cmc4
C-X9-C motif containing 4
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,448,452...74,460,190
Ensembl chr X:74,448,452...74,460,190
G
Ctag2l2
CTAG2 like 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,784,533...73,785,794
Ensembl chr X:73,784,533...73,785,794
G
Dkc1
dyskeratosis congenita 1, dyskerin
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:74,139,460...74,153,382
Ensembl chr X:74,139,460...74,153,383
G
Dnase1l1
deoxyribonuclease 1-like 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,316,823...73,325,939
Ensembl chr X:73,316,823...73,325,943
G
Dusp9
dual specificity phosphatase 9
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,682,995...72,687,120
Ensembl chr X:72,683,025...72,687,120
G
Emd
emerin
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,298,297...73,305,188
Ensembl chr X:73,298,293...73,305,154
G
F8
coagulation factor VIII
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,213,950...74,426,342
Ensembl chr X:74,216,321...74,426,221
G
Fam3a
FAM3 metabolism regulating signaling molecule A
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,427,816...73,436,856
Ensembl chr X:73,428,325...73,436,878
G
Fam50a
family with sequence similarity 50, member A
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,356,589...73,363,761
Ensembl chr X:73,356,639...73,363,755
G
Flna
filamin, alpha
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
G
Fundc2
FUN14 domain containing 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,426,005...74,440,764
Ensembl chr X:74,426,005...74,440,065
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
ISO IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency | ClinVar Annotator: match by term: FAVISM, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Favism, susceptibility to | ClinVar Annotator: match by term: G6PD A- | ClinVar Annotator: match by term: G6PD MALAGA | ClinVar Annotator: match by term: G6PD MINNESOTA | ClinVar Annotator: match by term: G6PD SANTIAGO | ClinVar Annotator: match by term: G6PD SANTIAGO DE CUBA | ClinVar Annotator: match by term: G6PD SERRES
CTD ClinVar MouseDO
PMID:5448 PMID:16832 PMID:511159 PMID:736032 PMID:835572 PMID:848857 PMID:853376 PMID:1008056 PMID:1270075 PMID:1303173 PMID:1303182 PMID:1459579 PMID:1536798 PMID:1551674 PMID:1562739 PMID:1611091 PMID:1631957 PMID:1805484 PMID:1879833 PMID:1924316 PMID:1945893 PMID:1953767 PMID:1972698 PMID:1978554 PMID:1978555 PMID:1999339 PMID:1999409 PMID:2157298 PMID:2190319 PMID:2222408 PMID:2253938 PMID:2255919 PMID:2263506 PMID:2307454 PMID:2321910 PMID:2393028 PMID:2503817 PMID:2572288 PMID:2602358 PMID:2606066 PMID:2633878 PMID:2836867 PMID:2849540 PMID:2895981 PMID:2912069 PMID:2912886 PMID:3198117 PMID:3201886 PMID:3338798 PMID:3393536 PMID:3446582 PMID:3565372 PMID:3591235 PMID:3740052 PMID:4154774 PMID:4283789 PMID:4359638 PMID:4379606 PMID:4388132 PMID:4392654 PMID:4435794 PMID:4721339 PMID:4837298 PMID:4838696 PMID:4974311 PMID:5081671 PMID:5305539 PMID:5316621 PMID:5369703 PMID:5413384 PMID:5485383 PMID:5641629 PMID:5673160 PMID:5770172 PMID:5775246 PMID:5779160 PMID:5844610 PMID:6015571 PMID:6344088 PMID:6500558 PMID:6698555 PMID:6714978 PMID:6714986 PMID:6805883 PMID:7055648 PMID:7129446 PMID:7160841 PMID:7203486 PMID:7211845 PMID:7327562 PMID:7390473 PMID:7440223 PMID:7577654 PMID:7590755 PMID:7655862 PMID:7789945 PMID:7803800 PMID:7806085 PMID:7825590 PMID:7849299 PMID:7858267 PMID:7870632 PMID:7947239 PMID:7947250 PMID:7949118 PMID:7959686 PMID:7959695 PMID:8118045 PMID:8141125 PMID:8193373 PMID:8241497 PMID:8244337 PMID:8364584 PMID:8370579 PMID:8436389 PMID:8447319 PMID:8471773 PMID:8477268 PMID:8490627 PMID:8533762 PMID:8537082 PMID:8611726 PMID:8807085 PMID:8807321 PMID:8807322 PMID:8813094 PMID:8956035 PMID:9017974 PMID:9192788 PMID:9233561 PMID:9250351 PMID:9290617 PMID:9298828 PMID:9299858 PMID:9332310 PMID:9342374 PMID:9384614 PMID:9410474 PMID:9444913 PMID:9536098 PMID:9589612 PMID:9674740 PMID:9858856 PMID:10192449 PMID:10221015 PMID:10480214 PMID:10502785 PMID:10556177 PMID:10571945 PMID:10627140 PMID:10643148 PMID:10666231 PMID:10734064 PMID:10772881 PMID:10782016 PMID:10916676 PMID:11024211 PMID:11042039 PMID:11112389 PMID:11146567 PMID:11243133 PMID:11261779 PMID:11271380 PMID:11295127 PMID:11379875 PMID:11400791 PMID:11445808 PMID:11484161 PMID:11499668 PMID:11594515 PMID:11601226 PMID:11748843 PMID:11780463 PMID:11793482 PMID:11852882 PMID:11968085 PMID:12028056 PMID:12064901 PMID:12064902 PMID:12064920 PMID:12105841 PMID:12130518 PMID:12187030 PMID:12215013 PMID:12367584 PMID:12497642 PMID:12737938 PMID:12737940 PMID:12768444 PMID:12850494 PMID:14014720 PMID:14278484 PMID:14505231 PMID:14757424 PMID:14757426 PMID:15065213 PMID:15223006 PMID:15315792 PMID:15349799 PMID:15466166 PMID:15502081 PMID:15625830 PMID:15727905 PMID:15766741 PMID:15858258 PMID:15906717 PMID:15914531 PMID:15996881 PMID:16079115 PMID:16088936 PMID:16119988 PMID:16136268 PMID:16143877 PMID:16155737 PMID:16193512 PMID:16329560 PMID:16356170 PMID:16427346 PMID:16461316 PMID:16513531 PMID:16528451 PMID:16601897 PMID:16607506 PMID:16753852 PMID:16777444 PMID:16927025 PMID:16934959 PMID:16944148 PMID:17018380 PMID:17233850 PMID:17524386 PMID:17576681 PMID:17587269 PMID:17611006 PMID:17726510 PMID:17877203 PMID:17959407 PMID:18043863 PMID:18046504 PMID:18056001 PMID:18066402 PMID:18086567 PMID:18177777 PMID:18226470 PMID:18270558 PMID:18329300 PMID:18452027 PMID:18568599 PMID:18627054 PMID:18677765 PMID:19224086 PMID:19396829 PMID:19422023 PMID:19465117 PMID:19589177 PMID:19594365 PMID:19632868 PMID:19846429 PMID:20007901 PMID:20052779 PMID:20085579 PMID:20200584 PMID:20203002 PMID:20236109 PMID:20582980 PMID:20602793 PMID:20621077 PMID:20713184 PMID:20949590 PMID:21063220 PMID:21153663 PMID:21302115 PMID:21397531 PMID:21441392 PMID:21446359 PMID:21479984 PMID:21507207 PMID:21637675 PMID:21677401 PMID:21874587 PMID:21931771 PMID:21989994 PMID:22018328 PMID:22139979 PMID:22164279 PMID:22165289 PMID:22171972 PMID:22237549 PMID:22281021 PMID:22293322 PMID:22307442 PMID:22382802 PMID:22452742 PMID:22552160 PMID:22770933 PMID:22906047 PMID:22906837 PMID:22963789 PMID:22963798 PMID:23006493 PMID:23057857 PMID:23144702 PMID:23365477 PMID:23389243 PMID:23409742 PMID:23479361 PMID:23660394 PMID:23757202 PMID:23926329 PMID:23965028 PMID:24022758 PMID:24033266 PMID:24117340 PMID:24134566 PMID:24365856 PMID:24460025 PMID:24505519 PMID:24551785 PMID:24586352 PMID:24711023 PMID:24787449 PMID:24962355 PMID:25071003 PMID:25141282 PMID:25189226 PMID:25201310 PMID:25326637 PMID:25407525 PMID:25440321 PMID:25536053 PMID:25541721 PMID:25548459 PMID:25741868 PMID:25775246 PMID:25925739 PMID:26060661 PMID:26226515 PMID:26275698 PMID:26479991 PMID:26633385 PMID:26693676 PMID:26823837 PMID:26827633 PMID:26829728 PMID:26990548 PMID:27040960 PMID:27053284 PMID:27213370 PMID:27282571 PMID:27287612 PMID:27408423 PMID:27495838 PMID:27519946 PMID:27535533 PMID:27853304 PMID:27880809 PMID:27884173 PMID:27914961 PMID:27941691 PMID:27980749 PMID:28028996 PMID:28059001 PMID:28195434 PMID:28356147 PMID:28492532 PMID:28512736 PMID:28583873 PMID:28756180 PMID:28824188 PMID:28852037 PMID:29072585 PMID:29138396 PMID:29141760 PMID:29248304 PMID:29300386 PMID:29333274 PMID:29339739 PMID:29396846 PMID:30045279 PMID:30077011 PMID:30096395 PMID:30097005 PMID:30161219 PMID:30314477 PMID:30315739 PMID:30674319 PMID:30988594 PMID:31294066 PMID:31489982 PMID:31525211 PMID:31590661 PMID:31602632 PMID:31609781 PMID:31833391 PMID:31862010 PMID:31863082 PMID:32156605 PMID:32180910 PMID:32387441 PMID:32387609 PMID:32425388 PMID:32641076 PMID:32680472 PMID:32702756 PMID:32860008 PMID:32987391 PMID:33051526 PMID:33069889 PMID:33072997 PMID:33128437 PMID:33413378 PMID:33536406 PMID:33628497 PMID:33636823 PMID:33637102 PMID:33708821 PMID:34007417 PMID:34134107 PMID:34272389 PMID:34532700 PMID:34551338 PMID:34620237 PMID:34643346 PMID:34659341 PMID:34762759 PMID:34773909 PMID:34895177 PMID:34934109 PMID:34966093 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35606495 PMID:35695473 PMID:35753512 PMID:35840819 PMID:35845714 PMID:36089067 PMID:36150187 PMID:36212124 PMID:36212142 PMID:36315991 PMID:36353116 PMID:36681081 PMID:36703223 PMID:36704359 PMID:36949502 PMID:38066190 PMID:38308253 PMID:38645242 PMID:38970298 More...
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gab3
growth factor receptor bound protein 2-associated protein 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:74,032,151...74,128,511
Ensembl chr X:74,010,449...74,129,064
G
Gdi1
GDP dissociation inhibitor 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,348,618...73,355,473
Ensembl chr X:73,348,604...73,355,468
G
H2ab2
H2A.B variant histone 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:115,590,875...115,591,222
Ensembl chr X:115,590,875...115,591,222
G
Haus7
HAUS augmin-like complex, subunit 7
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,480,921...72,502,635
Ensembl chr X:72,480,921...72,502,650
G
Hcfc1
host cell factor C1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,986,400...73,011,430
Ensembl chr X:72,986,398...73,009,963
G
Idh3g
isocitrate dehydrogenase 3 (NAD+), gamma
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,822,569...72,830,471
Ensembl chr X:72,822,569...72,830,503
G
Ikbkg
inhibitor of kappaB kinase gamma
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency | ClinVar Annotator: match by term: G6PD A-
ClinVar
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9384614 PMID:9536098 PMID:9589612 PMID:10480214 PMID:10502785 PMID:10627140 PMID:11379875 PMID:11601226 PMID:11748843 PMID:11968085 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16427346 PMID:16601897 PMID:16607506 PMID:17576681 PMID:18046504 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19589177 PMID:19846429 PMID:21446359 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31862010 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34620237 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35840819 PMID:36212142 PMID:36353116 More...
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
G
L1cam
L1 cell adhesion molecule
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,897,384...72,924,843
Ensembl chr X:72,897,384...72,939,711
G
Lage3
L antigen family, member 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,395,768...73,397,224
Ensembl chr X:73,394,882...73,397,224
G
Magea5
MAGE family member A5
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,836,057...153,846,147
Ensembl chr X:153,836,057...153,846,141
G
Mecp2
methyl CpG binding protein 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
Mpp1
membrane protein, palmitoylated
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,153,339...74,174,622
Ensembl chr X:74,153,339...74,174,622
G
Mtcp1
mature T cell proliferation 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,454,048...74,460,190
Ensembl chr X:74,454,050...74,460,194
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,960,476...72,965,550
Ensembl chr X:72,960,479...72,965,550
G
Nsdhl
NAD(P) dependent steroid dehydrogenase-like
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:71,962,127...72,002,134
Ensembl chr X:71,962,163...72,002,120
G
Opn1mw
opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan)
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,171,072...73,194,362
Ensembl chr X:73,171,070...73,194,366
G
Pdzd4
PDZ domain containing 4
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,836,963...72,868,649
Ensembl chr X:72,836,965...72,868,575
G
Plxna3
plexin A3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,372,644...73,388,295
Ensembl chr X:73,372,672...73,388,295
G
Plxnb3
plexin B3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,800,564...72,816,116
Ensembl chr X:72,800,696...72,816,120
G
Pnck
pregnancy upregulated non-ubiquitously expressed CaM kinase
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,699,598...72,703,723
Ensembl chr X:72,699,600...72,703,723
G
Pnma3
paraneoplastic antigen MA3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,108,393...72,111,797
Ensembl chr X:72,108,393...72,111,797
G
Pnma5
paraneoplastic antigen family 5
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,077,587...72,083,315
Ensembl chr X:72,077,587...72,080,709
G
Pnma6e
PNMA family member 6E
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,438,793...72,442,418
Ensembl chr X:72,440,045...72,442,342
G
Rab39b
RAB39B, member RAS oncogene family
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,615,651...74,621,837
Ensembl chr X:74,615,652...74,621,837
G
Renbp
renin binding protein
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,965,727...72,974,408
Ensembl chr X:72,965,727...72,974,456
G
Rpl10
ribosomal protein L10
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,314,463...73,316,741
Ensembl chr X:73,314,418...73,316,741
G
Slc10a3
solute carrier family 10 (sodium/bile acid cotransporter family), member 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,412,823...73,416,955
Ensembl chr X:73,412,823...73,416,955
G
Slc6a8
solute carrier family 6 (neurotransmitter transporter, creatine), member 8
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,716,739...72,726,108
Ensembl chr X:72,716,756...72,726,108
G
Smim9
small integral membrane protein 9
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,189,663...74,207,362
Ensembl chr X:74,189,662...74,207,376
G
Srpk3
serine/arginine-rich protein specific kinase 3
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,818,011...72,822,531
Ensembl chr X:72,818,011...72,822,531
G
Ssr4
signal sequence receptor, delta
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:72,830,778...72,834,432
Ensembl chr X:72,830,634...72,834,436
G
Tafazzin
tafazzin, phospholipid-lysophospholipid transacylase
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,325,498...73,340,182
Ensembl chr X:73,325,518...73,333,757
G
Tex28
testis expressed 28
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,194,515...73,211,444
Ensembl chr X:73,194,550...73,211,444
G
Tktl1
transketolase-like 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,220,865...73,252,104
Ensembl chr X:73,220,865...73,252,106
G
Trex2
three prime repair exonuclease 2
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,477,311...72,478,949
Ensembl chr X:72,477,311...72,478,950
G
Ubl4a
ubiquitin-like 4A
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:73,409,324...73,412,154
Ensembl chr X:73,409,324...73,416,824
G
Vbp1
von Hippel-Lindau binding protein 1
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:74,557,903...74,578,552
Ensembl chr X:74,557,905...74,578,548
G
Zfp185
zinc finger protein 185
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,030,860...72,075,149
Ensembl chr X:72,030,945...72,075,149
G
Zfp92
zinc finger protein 92
ISO
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:72,454,555...72,473,980
Ensembl chr X:72,454,702...72,471,991
G
Ank3
ankyrin 3, epithelial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Apoe
apolipoprotein E
IMP
RGD
PMID:15007105
RGD:12904641
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Avp
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 2:153,984,800...153,991,137
Ensembl chr 2:153,984,800...153,991,139
G
C3
complement component 3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Dio3
deiodinase, iodothyronine type III
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dnmt3b
DNA methyltransferase 3B
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Ehmt2
euchromatic histone lysine N-methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
G
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
treatment sexual_dimorphism
ISO IEP
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Hc
hemolytic complement
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Igf1
insulin-like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541
G
Mecp2
methyl CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
Mir326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 7:99,201,476...99,201,570
Ensembl chr 7:99,201,476...99,201,570
G
Mir7b
microRNA 7b
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr17:56,549,988...56,550,098
Ensembl chr17:56,549,988...56,550,098
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
G
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Oprk1
opioid receptor, kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprl1
opioid receptor-like 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Per2
period circadian clock 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr14:65,638,931...65,662,908
Ensembl chr14:65,638,122...65,662,921
G
Pomc
pro-opiomelanocortin-alpha
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
Setd7
SET domain containing (lysine methyltransferase) 7
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 3:51,422,740...51,468,519
Ensembl chr 3:51,422,740...51,468,300
G
Slc25a12
solute carrier family 25 (mitochondrial carrier, Aralar), member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Tlr4
toll-like receptor 4
ameliorates
IMP
RGD
PMID:30312858
RGD:405866345
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Ube3a
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 7:58,871,891...58,960,585
Ensembl chr 7:58,878,498...58,961,284
G
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Atp5f1e
ATP synthase F1 subunit epsilon
ISO
mRNA:decreased expression:heart, mitochondrion (rat)
RGD
PMID:21251948
RGD:5131501
NCBI chr 2:174,302,868...174,305,894
Ensembl chr 2:174,302,865...174,305,898
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
ISO
mRNA:decreased expression:heart, mitochondrion (rat)
RGD
PMID:21251948
RGD:5131501
NCBI chr16:91,722,111...91,728,518
Ensembl chr16:91,722,102...91,728,575 Ensembl chr16:91,722,102...91,728,575
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30259626
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Gli1
GLI-Kruppel family member GLI1
ISO
RGD
PMID:25623978
RGD:12879410
NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
G
Shh
sonic hedgehog
ISO
RGD
PMID:25623978
RGD:12879410
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
Smo
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:24388991
RGD:12879411
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21075095
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:28921207
RGD:14975164
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Il16
interleukin 16
ISO
protein:increased expression:brain
RGD
PMID:14698845
RGD:1354526
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Daxx
Fas death domain-associated protein
ISO
mRNA:increased expression:liver:
RGD
PMID:17692352
RGD:9587799
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
G
Kdm3b
KDM3B lysine (K)-specific demethylase 3B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21262293
NCBI chr18:34,910,061...34,972,423
Ensembl chr18:34,910,100...34,971,713
G
Kdr
kinase insert domain protein receptor
ISO
RGD
PMID:20058324
RGD:5684396
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Alad
aminolevulinate, delta-, dehydratase
ISO
protein:decreased activity:blood (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21396434 PMID:23792432 PMID:24631795 PMID:16597373 PMID:19647414
RGD:1599014 , RGD:4144142
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Glul
glutamate-ammonia ligase
ISO
protein:increased expression:stellate ganglion
RGD
PMID:29457680
RGD:401794593
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Hfe
homeostatic iron regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20659343
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16700817
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mt4
metallothionein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19921116
NCBI chr 8:94,863,832...94,865,659
Ensembl chr 8:94,863,825...94,865,659
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:28178683
RGD:13440092
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Qdpr
quinoid dihydropteridine reductase
ISO
protein:increased activity:brain, caudate nucleus (rat)
RGD
PMID:2359144
RGD:5128598
NCBI chr 5:45,591,374...45,607,571
Ensembl chr 5:45,591,363...45,607,578
G
Ryr1
ryanodine receptor 1, skeletal muscle
ISO
mRNA:decreased expression:peripheral blood mononuclear cell
RGD
PMID:30661027
RGD:329812013
NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20692022 PMID:23433214
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Xpo5
exportin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28042866
NCBI chr17:46,513,737...46,554,524
Ensembl chr17:46,513,708...46,554,524
G
Xrcc3
X-ray repair complementing defective repair in Chinese hamster cells 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23803535
NCBI chr12:111,769,626...111,780,326
Ensembl chr12:111,769,626...111,780,307
G
Alad
aminolevulinate, delta-, dehydratase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:18778733
RGD:4144152
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Atp13a2
ATPase type 13A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22285144
NCBI chr 4:140,711,812...140,734,641
Ensembl chr 4:140,714,184...140,734,641
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442826
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12171760
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Htt
huntingtin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19845833
NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Mfn2
mitofusin 2
ISO
protein:decreased expression:striatum (rat)
RGD
PMID:28232070
RGD:12910738
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010209 PMID:22174044
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20089134
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Slc30a10
solute carrier family 30, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195 PMID:29429640
NCBI chr 1:185,187,045...185,200,959
Ensembl chr 1:185,187,045...185,200,959
G
Slc31a1
solute carrier family 31, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22465424
NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006
G
Slc39a14
solute carrier family 39 (zinc transporter), member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195
NCBI chr14:70,540,916...70,588,873
Ensembl chr14:70,540,918...70,588,874
G
Slc39a8
solute carrier family 39 (metal ion transporter), member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29429640
NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333
G
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23934647
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16891999
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Gpx1
glutathione peroxidase 1
IEP
RGD
PMID:18758054
RGD:7240571
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased activity:plasma
RGD
PMID:25975991
RGD:401827854
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased secretion:serum (rat)
RGD
PMID:20508868
RGD:4145621
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:28498799
RGD:13439738
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Ctsb
cathepsin B
ISO
RGD
PMID:18638529
RGD:2315510
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Jun
jun proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15515958
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
S100b
S100 protein, beta polypeptide, neural
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29566083
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31351185
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Ins2
insulin II
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26364587
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Alad
aminolevulinate, delta-, dehydratase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21439310
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Ep300
E1A binding protein p300
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24291742
RGD:9588309
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Slc6a1
solute carrier family 6 (neurotransmitter transporter, GABA), member 1
ISO
protein:increased expression:brain, synaptosome
RGD
PMID:15149801
RGD:1643208
NCBI chr 6:114,259,735...114,294,491
Ensembl chr 6:114,259,596...114,294,493
G
Ache
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:3669600 PMID:8359835 PMID:23000449
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:22981459 PMID:22982776 PMID:23044488 PMID:23123253 PMID:23178380 PMID:23220586 PMID:26239905 PMID:31201777 More...
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24188896
RGD:10401876
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Pepd
peptidase D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22982776
NCBI chr 7:34,611,832...34,744,131
Ensembl chr 7:34,611,804...34,744,133
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:11022865 PMID:20581384 PMID:20981111 PMID:23123254 PMID:24326413 PMID:26340881 PMID:28070599 More...
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Ager
advanced glycosylation end product-specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agtr1a
angiotensin II receptor, type 1a
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Agtr1b
angiotensin II receptor, type 1b
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:20,368,637...20,421,341
Ensembl chr 3:20,368,637...20,421,341
G
Akt1
thymoma viral proto-oncogene 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597931096 , RGD:597830178 , RGD:597830151
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Bace1
beta-site APP cleaving enzyme 1
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdnf
brain derived neurotrophic factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Gdnf
glial cell line derived neurotrophic factor
treatment
ISO IEP
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Igf1
insulin-like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597830178 , RGD:597830151
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfbp7
insulin-like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888
G
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:30221701 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597931096 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:30221701 PMID:28684969
RGD:401965467 , RGD:597931096 , RGD:597538492
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 9:54,769,942...54,819,812
Ensembl chr 9:54,771,073...54,819,814
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mir320
microRNA 320
treatment
ISO
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
Ngf
nerve growth factor
treatment
IEP ISO
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
treatment
ISO IEP IMP
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression:lung, skin, plasma
RGD
PMID:24831016
RGD:11341687
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Ache
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr10:114,914,546...115,020,927
Ensembl chr10:114,914,546...115,020,927
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
Akt1
thymoma viral proto-oncogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Camk2b
calcium/calmodulin-dependent protein kinase II, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362
G
Esr1
estrogen receptor 1 (alpha)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Grm2
glutamate receptor, metabotropic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 9:106,521,733...106,533,308
Ensembl chr 9:106,520,294...106,533,281
G
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Htr6
5-hydroxytryptamine (serotonin) receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 4:138,787,017...138,802,881
Ensembl chr 4:138,788,419...138,802,881
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Pick1
protein interacting with C kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr15:79,113,373...79,133,666
Ensembl chr15:79,113,373...79,133,684
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr11:109,116,174...109,189,013
Ensembl chr11:109,116,181...109,188,955
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
ISO
associated with schizophrenia
RGD
PMID:10889552
RGD:1358545
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Drd3
dopamine receptor D3
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
susceptibility
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: 3435T>C(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12352921 PMID:17938643
RGD:11081146
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
susceptibility
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :421C>A(human)
RGD
PMID:17938643
RGD:11081146
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Adcyap1
adenylate cyclase activating polypeptide 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29604313
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr19:53,128,874...53,235,518
Ensembl chr19:53,128,874...53,235,830
G
Adra1b
adrenergic receptor, alpha 1b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19125850
NCBI chr11:43,665,432...43,792,076
Ensembl chr11:43,665,433...43,792,037
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21620937
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2l1
BCL2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21972528
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Cat
catalase
ISO
protein:decreased activity:serum:
RGD
PMID:16938375
RGD:9068882
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cck
cholecystokinin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cd3d
CD3 antigen, delta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 9:44,893,067...44,898,350
Ensembl chr 9:44,893,084...44,898,637
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 8:120,719,177...120,779,533
Ensembl chr 8:120,719,177...120,779,532
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21225912
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Drd2
dopamine receptor D2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19576243
RGD:2311553
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Epha4
Eph receptor A4
ISO
RGD
PMID:10336070
RGD:5688752
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephx1
epoxide hydrolase 1, microsomal
susceptibility
ISO
DNA:missense mutation:cds:p.H139R (human)
RGD
PMID:17022435
RGD:5490249
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Fos
FBJ osteosarcoma oncogene
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19220411
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gabrr2
gamma-aminobutyric acid type A receptor subunit rho 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 4:33,057,715...33,095,865
Ensembl chr 4:33,062,999...33,095,865
G
Gstm1
glutathione S-transferase, mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:8923609 PMID:27220440
RGD:5490214 , RGD:14700956
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstp1
glutathione S-transferase, pi 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:17022435
RGD:5490249
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Igf1r
insulin-like growth factor I receptor
ISO
DNA: snp: intron: rs1879612: bortezomib induced
RGD
PMID:20864405
RGD:5686413
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:23916895
RGD:7364985
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Lat
linker for activation of T cells
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 7:125,962,999...125,968,877
Ensembl chr 7:125,962,996...125,968,742
G
Mtor
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16955484
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20211941
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32014472
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20849151
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
P2rx1
purinergic receptor P2X, ligand-gated ion channel, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr11:72,889,882...72,906,026
Ensembl chr11:72,889,929...72,906,026
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442825
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21329748
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Prkcd
protein kinase C, delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22512859
NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
G
Ptges3
prostaglandin E synthase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr10:127,894,851...127,913,123
Ensembl chr10:127,894,823...127,913,141
G
Rnase6
ribonuclease, RNase A family, 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr14:51,361,365...51,369,644
Ensembl chr14:51,361,365...51,369,644
G
Slc18a2
solute carrier family 18 (vesicular monoamine), member 2
ISO
protein:increased expression:thalamus (rat)
RGD
PMID:19798748
RGD:5130970
NCBI chr19:59,249,310...59,284,444
Ensembl chr19:59,249,328...59,284,444
G
Snhg12
small nucleolar RNA host gene 12
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35410500
NCBI chr 4:132,035,989...132,038,335
Ensembl chr 4:132,035,905...132,038,762
G
Srsf5
serine and arginine-rich splicing factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr12:80,992,308...80,997,277
Ensembl chr12:80,992,278...80,997,281
G
St8sia1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 6:142,767,267...142,935,247
Ensembl chr 6:142,767,271...142,910,178
G
Tgm1
transglutaminase 1, K polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383
G
Timp3
tissue inhibitor of metalloproteinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Oxt
oxytocin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:292422 PMID:803783 PMID:3923190 PMID:4988877 PMID:5067144 PMID:5493616 PMID:5528113 PMID:7360068 More...
NCBI chr 2:130,416,432...130,418,974
Ensembl chr 2:130,418,093...130,418,974
G
Uts2
urotensin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16160878
NCBI chr 4:151,081,554...151,086,267
Ensembl chr 4:151,081,554...151,086,267
G
Avp
arginine vasopressin
ISO
associated with alcohol dependence;protein:increased expression:plasma protein:decreased expression:cerebrospinal fluid
RGD
PMID:7662042 PMID:2425205
RGD:596933082 , RGD:596933106
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
Pomc
pro-opiomelanocortin-alpha
ISO
protein:increased expression:mammillary body
RGD
PMID:1650797
RGD:407572523
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all